Philippe Beutels, Ph.D.
Affiliations: | 2002 | Universitaire Instelling Antwerpen (Belgium) |
Area:
Public Health, General EconomicsGoogle:
"Philippe Beutels"Cross-listing: PHTree
Parents
Sign in to add mentor| P Van Damme | grad student | 2002 | Universitaire Instelling Antwerpen (Belgium) | |
| (Economic evaluation of vaccination programmes in humans: A methodological exploration with applications to hepatitis B, varicella -zoster, measles, pertussis, hepatitis A and pneumococcal vaccination.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Affaticati F, Bartholomeus E, Mullan K, et al. (2023) Multi-View Learning to Unravel the Different Levels Underlying Hepatitis B Vaccine Response. Vaccines. 11 |
| Koltai M, Moyes J, Nyawanda B, et al. (2023) Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. Bmc Medicine. 21: 120 |
| Varbanova V, Verelst F, Hens N, et al. (2022) Determinants of basic childhood vaccination coverage in European and OECD countries. Human Vaccines & Immunotherapeutics. 2123883 |
| Mazur NI, Terstappen J, Baral R, et al. (2022) Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. The Lancet. Infectious Diseases |
| Luyten J, Beutels P, Vandermeulen C, et al. (2022) Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment. Social Science & Medicine (1982). 303: 114991 |
| Franco N, Coletti P, Willem L, et al. (2022) Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data. Plos Computational Biology. 18: e1009965 |
| Iftekhar EN, Priesemann V, Balling R, et al. (2021) A look into the future of the COVID-19 pandemic in Europe: an expert consultation. The Lancet Regional Health. Europe. 100185 |
| Bartholomeus E, De Neuter N, Suls A, et al. (2020) Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. Vaccine |
| Keersmaekers N, Ogunjimi B, Van Damme P, et al. (2019) An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix. Vaccine |
| Willem L, Blommaert A, Hanquet G, et al. (2018) Economic Evaluation of Pneumococcal Vaccines for Adults Aged Over 50 Years in Belgium. Human Vaccines & Immunotherapeutics. 0 |